Skip to content

Artificial Intelligence-Driven Multi-Omics Data Analysis for Early Warning of Severe Pneumonia and Exploration of Improved Diagnostic and Treatment Strategies

Artificial Intelligence-Driven Multi-Omics Data Analysis for Early Warning of Severe Pneumonia and Exploration of Improved Diagnostic and Treatment Strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095442
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe community-acquired pneumonia

Interventions

Severe community-acquired pneumonia group(SCAP group):None
Community-acquired pneumonia group(CAP group):None

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >18 years old; 2. The diagnosis of CAP was in accordance with "Chinese Guidelines for the Diagnosis and treatment of adult Community-acquired pneumonia (2016 edition)". The Diagnosis of SCAP was in accordance with the "Diagnosis and Treatment of adults with Community-acquired Pneumonia. An Official Clinical" published by the ATS Association in 2019 Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. The details are as follows: (1) Diagnostic criteria of CAP: 1) Community-onset. 2) Pneumonia-related clinical manifestations: a. recent cough, expectoration, or worsening of symptoms of preexisting respiratory diseases, with or without sputum purulence, chest pain, dyspnea, and hemoptysis; b. Fever; c. signs of pulmonary consolidation and/or moist rales; d. White blood cell count > 10×10^9/L or =7.12mmol/L; f. White blood cell count < 4×10^9/L; g. Thrombocytopenia <=100×10^9/L; h. hypothermia, body temperature < 36 ° C; i. Systolic blood pressure < 90mmHg requiring aggressive fluid resuscitation.

Exclusion criteria

Exclusion criteria: 1. Long-term residence in a nursing home; 2. Patients with tracheostomy; 3. Patients with hospital-acquired infections; 4. Advanced-stage malignant tumor patients with an expected survival of less than 3 months; 5. Immunosuppressed state with concurrent infection.

Design outcomes

Primary

MeasureTime frame
Upper Respiratory Tract Pathogenology;Pulmonary Pathogenology;Peripheral Blood Mononuclear Cells;

Secondary

MeasureTime frame
Serum Immune and Inflammatory Factors;

Countries

China

Contacts

Public ContactHongru Li

Fujian Provincial Hospital

muzi131122@163.com+86 186 5030 8626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026